Kisspeptin and Menopause Research: KNDy Biology and Trial Limits

Explore kisspeptin menopause research, KNDy-neuron biology, the Imperial postmenopausal trial, NK3R drug distinctions, and the evidence still missing.
This website sells research materials for laboratory use only. You must be at least 21 years old to enter.
We're sorry. You must be at least 21 years old to access this site.

Explore kisspeptin menopause research, KNDy-neuron biology, the Imperial postmenopausal trial, NK3R drug distinctions, and the evidence still missing.

Selank research overview for women 40+: tuftsin-analog structure, GABA-A and BDNF study findings, the small human-trial record, and what remains unproven.

Explore PT-141 and bremelanotide research in women, including melanocortin biology, phase 3 trials, FDA scope, midlife evidence gaps, and key limits.

A 2026 Neurology cohort study linked estrogen-only menopausal hormone therapy with lower odds of Alzheimer pathology. Review the findings and limits.

Review glutathione and oxidative stress research in aging, menopause, redox biology, skin studies, evidence limits, and questions for women over 40.

Explore cagrilintide research, amylin biology, CagriSema trial results, evidence limits, and what women over 40 should know about the research gap.

A 2026 dermatology review examined GLP-1 receptors in major skin cell types. Learn what the evidence shows—and what researchers still need to establish.
Peptide Research and Healthy Aging Trending: A Wider Healthy-Aging Lens A new 2026 scientific review is bringing aesthetic, metabolic, and endocrine peptide research into one conversation. Topics such as GHK-Cu are being studied alongside broader questions about skin biology, cellular…
A concise MOTS-c research brief for women over 40 with Luvi peptide education resources and a research-reading tip.
GLP-1 wellness research for women over 40: fall-risk literature, healthy-aging context, Luvi education resources, and research-only reading tips.